| Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Confidence score
|
Ref.
|
| acc1651 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Lung Cancer |
A549 |
Doxorubicin |
Impairing |
5.0 |
31848319
|
| acc1652 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Prostate Cancer |
DU145 |
Boric acid |
Associated |
4.0 |
30196486
|
| acc1653 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Breast Cancer |
T47D |
Lapatinib |
Impairing |
5.0 |
32365111
|
| acc1654 |
eIF4E |
phosphorylation |
Ser209 |
human |
Thyroid Cancer |
FTC-133 |
Rifabutin |
Associated |
4.0 |
28864377
|
| acc1655 |
eIF4E |
phosphorylation |
Ser209 |
human |
Thyroid Cancer |
8505C |
Rifabutin |
Associated |
4.0 |
28864377
|
| acc1656 |
eIF4E |
phosphorylation |
Ser209 |
human |
Thyroid Cancer |
FTC-133 |
Paclitaxel |
Impairing |
5.0 |
28864377
|
| acc1657 |
eIF4E |
phosphorylation |
Ser209 |
human |
Thyroid Cancer |
8505C |
Paclitaxel |
Impairing |
5.0 |
28864377
|
| acc1658 |
eIF4E |
phosphorylation |
Ser209 |
human |
Lung Cancer |
H3255 |
Rifabutin |
Associated |
4.0 |
26944016
|
| acc1659 |
beta-catenin |
phosphorylation |
Ser552 |
human |
Lung Cancer |
H3255 |
Rifabutin |
Associated |
4.0 |
26944016
|
| acc1660 |
eIF4E |
phosphorylation |
Ser209 |
human |
Pancreas Cancer |
PC-346C |
RAD001 |
Impairing |
5.0 |
28745319
|
| acc1661 |
eIF4E |
phosphorylation |
Ser209 |
human |
Pancreas Cancer |
C4-2 |
RAD001 |
Impairing |
5.0 |
28745319
|
| acc1662 |
eIF4E |
phosphorylation |
Ser209 |
human |
Glioma |
U373 |
Temozolomide |
Impairing |
5.0 |
27289018
|
| acc1663 |
eIF4E |
phosphorylation |
Ser209 |
human |
Glioma |
LN229 |
Temozolomide |
Impairing |
5.0 |
27289018
|
| acc1664 |
endoglin |
phosphorylation |
Thr |
human |
Prostate Cancer |
PC3-M |
TGF-beta1 |
Associated |
4.0 |
19736306
|
| acc1665 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1666 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
Hep3B |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1667 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
HuH6 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1668 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
PLC/PRF5 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1669 |
HER3 |
phosphorylation |
Tyr1289 |
human |
Hepatocellular Carcinoma |
HepG2 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1670 |
HER3 |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
Hep3B |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1671 |
HER3 |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
HuH6 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1672 |
HER3 |
phosphorylation |
Tyr1068 |
human |
Hepatocellular Carcinoma |
PLC/PRF5 |
Sorafenib |
Impairing |
5.0 |
22414764
|
| acc1673 |
EGFR |
phosphorylation |
unclear |
human |
Thyroid Cancer |
|
Apigenin |
Associated |
4.0 |
11299771
|
| acc1674 |
ERK |
phosphorylation |
unclear |
human |
Thyroid Cancer |
|
Apigenin |
Associated |
4.0 |
11299771
|
| acc1675 |
Rb |
phosphorylation |
unclear |
human |
Breast Cancer |
MCF7 |
Apigenin |
Associated |
4.0 |
11299771
|
| acc1676 |
ERK |
phosphorylation |
unclear |
human |
Breast Cancer |
MDA-MB-468 |
Apigenin |
Associated |
4.0 |
11299771
|
| acc1677 |
ERalpha |
phosphorylation |
Ser118 |
human |
Breast Cancer |
MCF7 |
LY294002 |
Impairing |
5.0 |
18941890
|
| acc1678 |
ERalpha |
phosphorylation |
Ser167 |
human |
Breast Cancer |
MCF7 |
LY294002 |
Impairing |
5.0 |
18941890
|
| acc1679 |
ERalpha |
phosphorylation |
Ser118 |
human |
Breast Cancer |
MCF7 |
ICI182780 |
Impairing |
5.0 |
18941890
|
| acc1680 |
ERalpha |
phosphorylation |
Ser167 |
human |
Breast Cancer |
MCF7 |
ICI182780 |
Impairing |
5.0 |
18941890
|
| acc1681 |
ERalpha |
phosphorylation |
Ser118 |
rat |
Prolactinoma |
MMQ/BRO |
Bromocriptine |
Impairing |
5.0 |
33173437
|
| acc1682 |
ERalpha |
phosphorylation |
Ser118 |
human |
Prolactinoma |
|
Bromocriptine |
Impairing |
5.0 |
33173437
|
| acc1683 |
ERG |
phosphorylation |
Ser96 |
human |
Prostate Cancer |
HEK293T |
TAK-242 |
Associated |
4.0 |
33554122
|
| acc1684 |
ERK1 |
phosphorylation |
Thr202 |
human |
Glioma |
C6 |
Temozolomide |
Associated |
4.0 |
27878252
|
| acc1685 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Glioma |
C6 |
Temozolomide |
Associated |
4.0 |
27878252
|
| acc1686 |
ERK2 |
phosphorylation |
Thr185 |
human |
Glioma |
C6 |
Temozolomide |
Associated |
4.0 |
27878252
|
| acc1687 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Glioma |
C6 |
Temozolomide |
Associated |
4.0 |
27878252
|
| acc1688 |
ERK1 |
phosphorylation |
Thr202 |
human |
Glioma |
C6 |
U0126 |
Impairing |
5.0 |
27878252
|
| acc1689 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Glioma |
C6 |
U0126 |
Impairing |
5.0 |
27878252
|
| acc1690 |
ERK2 |
phosphorylation |
Thr185 |
human |
Glioma |
C6 |
U0126 |
Impairing |
5.0 |
27878252
|
| acc1691 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Glioma |
C6 |
U0126 |
Impairing |
5.0 |
27878252
|
| acc1692 |
ERK1 |
phosphorylation |
Thr202 |
human |
Stomach Cancer |
|
Vitamin K3 |
Associated |
4.0 |
12678906
|
| acc1693 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Stomach Cancer |
|
Vitamin K3 |
Associated |
4.0 |
12678906
|
| acc1694 |
ERK2 |
phosphorylation |
Thr185 |
human |
Stomach Cancer |
|
Vitamin K3 |
Associated |
4.0 |
12678906
|
| acc1695 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Stomach Cancer |
|
Vitamin K3 |
Associated |
4.0 |
12678906
|
| acc1696 |
ERK1 |
phosphorylation |
Thr202 |
human |
Colorectal Cancer |
HCT116 |
DHA + ISL |
Associated |
4.0 |
33502699
|
| acc1697 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Colorectal Cancer |
HCT116 |
DHA + ISL |
Associated |
4.0 |
33502699
|
| acc1698 |
ERK2 |
phosphorylation |
Thr185 |
human |
Colorectal Cancer |
HCT116 |
DHA + ISL |
Associated |
4.0 |
33502699
|
| acc1699 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Colorectal Cancer |
HCT116 |
DHA + ISL |
Associated |
4.0 |
33502699
|
| acc1700 |
ERK1 |
phosphorylation |
Thr202 |
human |
Ovarian Cancer |
A2780AD |
PTX |
Impairing |
5.0 |
29693189
|
